Skip to content

Patients With Hidradenitis vs Patients With Psoriasis: Psychological Impact

A Comparative Retrospective Study Between Patients With Hidradenitis vs Patients With Psoriasis: Psychological Impact

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02999698
Enrollment
100
Registered
2016-12-21
Start date
2017-02-28
Completion date
2017-06-30
Last updated
2016-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hidradenitis, Psoriasis

Keywords

Psoriasis, Hidradenitis, Psychological impact, Quality of life

Brief summary

The aim of this study is to evaluate the psychological impact of psoriasis or hidradenitis suppurativa on patients, in order to compare both pathologies.

Interventions

OTHERObservational

Observational

Sponsors

Universitat Autonoma de Barcelona
CollaboratorOTHER
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Lead SponsorOTHER

Study design

Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Men and women at least 18 years old at the time of selection. * Subjects diagnosed with psoriasis or hidradenitis suppurativa * Subjects who had completed the questionnaires for psychological impact. * Patients should be able to understand and communicate with the investigator.

Exclusion criteria

* Subjects suffering from a serious concomitant illness. * Subjects with a mental illness. * Subjects who are performing psychiatric treatment. * Patients who have alcohol dependence or drug abuse. * Subjects that present legal incapacity or limited legal capacity. * Subjects presenting illiteracy or language barriers.

Design outcomes

Primary

MeasureTime frameDescription
The Holmes and Rahe stress scale1 dayThe Holmes and Rahe stress scale is a list of 43 stressful life events that can contribute to illness.
Dermatology Quality of Life Index (DLQI)1 dayThe Dermatology Life Quality Index or DLQI, developed in 1994, was the first dermatology-specific Quality of Life instrument. It is a simple 10-question validated questionnaire that has been used in over 40 different skin conditions in over 80 countries and is available in over 90 languages. Its use has been described in over 1000 publications including many multinational studies. The DLQI is the most frequently used instrument in studies of randomised controlled trials in dermatology.
Hospital Anxiety and Depression Scale (HADS)1 dayHospital Anxiety and Depression Scale (HADS) was originally developed by Zigmond and Snaith (1983) and is commonly used by doctors to determine the levels of anxiety and depression that a patient is experiencing. The HADS is a fourteen item scale that generates ordinal data. Seven of the items relate to anxiety and seven relate to depression.
Perceived Stress Scale (PSS)1 dayPerceived Stress Scale (PSS) was originally developed by Cohen (1983) and this scale is a self-report instrument that evaluates the level of stress perceived during the last month. The scale consists of 14 items with a response format of a five-point scale (0 = never, 1 = almost never, 2 = Every now and then, 3 = often, 4 = very often). The score obtained indicates that a higher score corresponds to a higher level of perceived stress.

Secondary

MeasureTime frameDescription
Psoriasis Area Severity Index (PASI)1 dayThe Psoriasis Area Severity Index (PASI) is an index used to express the severity of psoriasis. It combines the severity (erythema, induration and desquamation) and percentage of affected area.
Static Physician's Global Assessment (sPGA)1 dayThe PGA is a 5 point ordinal rating ranging from clear to very severe psoriasis.
Hurley's staging system1 dayHurley separated patients into three groups based largely on the presence and extent of cicatrization and sinuses. It has been used as a basis for clinical trials in the past and is a useful basis to approach therapy for patients. These three stages are based on Hurley's staging system, which is simple and relies on the subjective extent of the diseased tissue the patient has. Hurley's three stages of hidradenitis suppurativa.
Hidradenitis Suppurativa - Physician Global Assessment (HS-PGA)1 dayThe six-point Physician Global Assessment (PGA) ranges from clear to very severe. It is used in clinical trials to measure clinical improvement in inflammatory nodules, abscesses and draining fistulae

Contacts

Primary ContactEsther Margarit de Miguel, Msc
emargarit@santpau.cat+34696617013
Backup ContactEva Vilarrasa Rull, Dr.
evilarrasa@santpau.cat+34935537007

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026